NutraCea, a world leader in stabilized rice bran (SRB) nutrient research and technology, today announced that W. John Short, 60, has been appointed President of the company, effective July 6, 2009. Short will report to Interim CEO James C. Lintzenich and be responsible for the operations of the Company.
Short brings over 25 years experience to this newly created position having held senior positions with consumer products and financial services businesses in North America, South America, Asia and Europe including President & COO of Hong Kong-based Esprit Far East Ltd., CEO of Dusseldorf-based Esprit Europe, CEO of San Francisco-based global licensing company Esprit International, CEO/President & COO of Joe Boxer, Inc. and EVP North America of Miami based Sunglass Hut International where he was responsible for 2,000 retail stores and 7,000 employees. Short also spent over a decade in corporate banking, government lending and financial institutions lending with Citibank in New York, Venezuela, Ecuador and Hong Kong.
David Bensol, Chairman of the Board, commented, "We are pleased to have John join our management team. He has demonstrated success in developing and implementing brand, sales and operating management strategies for highly recognized international companies, as well as constructing complex supply chains around the world. This experience will be extremely valuable to NutraCea as we continue in our efforts to grow our business world-wide."
Short said, "I am joining NutraCea at a demanding time in the company's evolution. In spite of numerous short term challenges, the company's significant asset base and unique technology provide a solid platform for future profitable growth. I look forward to working with the existing management team and the Board to produce the results that NutraCea's shareholders expect."
Short earned dual under graduate degrees in economics and Spanish from Dartmouth College and an MBA summa cum laude from the Thunderbird School of Global Management.
NutraCea is a world leader in production and utilization of stabilized rice bran. NutraCea holds many patents for stabilized rice bran production technology and proprietary neutraceutical formulas ranging from arthritis, chronic bowel conditions, and effective diabetes control to cardiovascular disease treatment protocols. NutraCea's proprietary technology enables the creation of food and nutrition products to be unlocked from rice bran, normally a waste by-product of standard rice processing. Committed to helping the underfed, they're heavily involved in providing product and technology for developing countries through NutraCea's RiceAde feeding program. More information can be found in the Company's filings with the SEC, and you can visit the NutraCea Web site http://www.NutraCea.com
This release contains forward-looking statements, including statements regarding future worldwide growth of NutraCea's business. These statements are made based upon current expectations and actual results may differ from those projected, due to various risks and uncertainties. NutraCea does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information. Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in NutraCea's filings with the Securities and Exchange Commission, including NutraCea's most recent periodic reports.